A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics of HRS4800 in Healthy Subjects

NCT04991909 ↗

Phase 1 Unknown 96 enrolled Jiangsu HengRui Medicine Co., Ltd.

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study is being conducted to assess the safety and tolerability of HRS4800 after multiple oral administration with different dose regimens in healthy subjects.

Timeline

Start: 2021-08-23
Primary completion: 2022-05-30
Completion: 2022-05-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS4800	Unknown	—	Oral

Indications

No indication recorded.